Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

CEO Anne Wojcicki told investors on an earnings call Tuesday that the moves are “difficult but necessary actions that we ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The company’s chief executive, Anne Wojcicki, has said she is committed to customer privacy and will “maintain our current ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

At Mar-a-Lago, ‘Uncle’ Elon Musk Puts His Imprint on the Trump Transition He’s on the patio. He’s on the golf course. Everywhere President-elect Trump looks, there is the world’s richest ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...